Single arm feasibility trial of a mobile application for adolescent migraine management

• by Amy E Noser, Abigail S Robbertz, James Peugh, Marielle Kabbouche, Joanne Kacperski, Scott W Powers, Andrew D Hershey, Kevin A Hommel

• November 5, 2024

The association between social risk profile and self-reported severe headache or migraine with all-cause mortality risk: A machine learning-based prediction model and interpretability analysis

• by Mengjie Zhao, Jing Cao, Zirong Li, Fang Lu, Qiuyan Li

• July 4, 2026

CGRP Therapies May Reduce Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies.

• by Andrea Surnit

• May 20, 2026

• 3 min

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

Board-certified neurologist Zack Z. Ramilevich, M.D., has joined Marcus Neuroscience Institute, part of Baptist Health, as a general neurologist.

• March 26, 2026

• 2 min